Document is current
Any future updates will be listed below
-
Authors
Calvisi, Diego F. https://orcid.org/0000-0002-6038-8567
Boulter, Luke https://orcid.org/0000-0002-7954-6705
Vaquero, Javier https://orcid.org/0000-0002-6020-6962
Saborowski, Anna
Fabris, Luca https://orcid.org/0000-0001-8538-6317
Rodrigues, Pedro M. https://orcid.org/0000-0001-6193-7436
Coulouarn, Cédric
Castro, Rui E. https://orcid.org/0000-0002-7417-0091
Segatto, Oreste
Raggi, Chiara https://orcid.org/0000-0003-2473-3535
van der Laan, Luc J. W. https://orcid.org/0000-0002-0651-5334
Carpino, Guido https://orcid.org/0000-0001-8570-2519
Goeppert, Benjamin https://orcid.org/0000-0002-4135-9250
Roessler, Stephanie https://orcid.org/0000-0002-5333-5942
Kendall, Timothy J. https://orcid.org/0000-0002-4174-2786
Evert, Matthias
Gonzalez-Sanchez, Ester https://orcid.org/0000-0002-9636-9624
Valle, Juan W. https://orcid.org/0000-0002-1999-0863
Vogel, Arndt https://orcid.org/0000-0003-0560-5538
Bridgewater, John https://orcid.org/0000-0001-9186-1604
Borad, Mitesh J.
Gores, Gregory J. https://orcid.org/0000-0003-3151-009X
Roberts, Lewis R. https://orcid.org/0000-0001-7885-8574
Marin, Jose J. G. https://orcid.org/0000-0003-1186-6849
Andersen, Jesper B. https://orcid.org/0000-0003-1760-5244
Alvaro, Domenico
Forner, Alejandro https://orcid.org/0000-0002-9014-4950
Banales, Jesus M. https://orcid.org/0000-0002-5224-2373
Cardinale, Vincenzo
Macias, Rocio I. R. https://orcid.org/0000-0002-4748-0326
Vicent, Silve https://orcid.org/0000-0002-9457-6881
Chen, Xin
Braconi, Chiara
Verstegen, Monique M. A.
Fouassier, Laura https://orcid.org/0000-0001-6377-5610
,
Roberts, Lewis
Scheiter, Alexander
Selaru, Florin M.
Evert, Katja
Utpatel, Kirsten
Broutier, Laura
Cadamuro, Massimiliano
Huch, Meritxell
Goldin, Robert
Gradilone, Sergio A.
Saito, Yoshimasa
- License Information
-
More Information
Article History
Accepted: 20 December 2022
First Online: 8 February 2023
Competing interests
: C.B. receives honoraria from Incyte, Servier, BI and AstraZeneca, and research funding from Avacta and Medannex. A.F. received consultancy fees from Bayer, AstraZeneca, Roche, Boston, Exact Science and Guerbert. J.W.V. reports honoraria from Agios, AstraZeneca, Genoscience Pharma, Incyte, Mundipharma EDO, Mylan, QED, Servier, SIRTex and Zymeworks, and honoraria and non-financial support from NuCana, all outside the submitted work. The other authors declare no competing interests.
Free to read: This content has been made available to all.
